ARCHIVES

New Drug Reverses Damage To Liver In Stem Cell Transplant

This article is from The Cancer Letter archive.

Vol. 25 No. 9 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Low Dose DFMO Reduces Colon Adenoma Recurrence

April 25, 2008

ODAC Okays First “Paper NDA,” By BMS For Bieomycin

October 1, 1993

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

February 14, 1986

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

ACS, In Reorganization, To Emphasize Funds for Young Scientists

January 12, 1996

DCCR Plans Three Multiple Contracts In Pain Control

February 17, 1978